Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Staphylococcus aureus SaeRS two-component system is a master regulatory network that controls the expression of numerous virulence factors, including alpha-hemolysin, leukocidins, and coagulase, which are vital for the pathogen's survival and evasion of the host immune system [1.2.1, 1.3.1]. The system consists of the sensor histidine kinase SaeS and the response regulator SaeR, which together sense environmental cues—such as human neutrophil peptides and hydrogen peroxide—to trigger a transcriptional response [1.2.1, 1.3.3]. Upon activation, SaeS autophosphorylates and transfers the phosphate group to SaeR, which then binds to specific DNA sequences to regulate gene expression [1.3.1, 1.3.3]. Because the SaeRS system is essential for staphylococcal pathogenesis but not for basic bacterial growth, it is considered a high-priority target for anti-virulence therapy [1.2.2, 1.4.1]. Inhibitors such as fenoprofen and phenazopyridine have been identified to disrupt this signaling pathway, effectively reducing the production of toxins and enhancing the host's ability to clear the infection [1.2.1, 1.4.3]. This anti-virulence approach aims to disarm the bacteria rather than kill them, potentially reducing the selective pressure for antibiotic resistance [1.4.1, 1.4.3].
Inhibition of sensor kinase autophosphorylation and inhibition of response regulator DNA binding
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Staphylococcus aureus SaeRS two-component system (SaeRS).